Opium Withdrawal Syndrome – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Opium Withdrawal Syndrome – Drugs In Development, 2024 report and make more profitable business decisions.
Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. Opioid withdrawal is a set of symptoms arising from the sudden withdrawal or reduction of opioids where previous usage has been heavy and prolonged. Signs and symptoms of withdrawal can include drug craving, anxiety, restless legs, nausea, vomiting, diarrhea, sweating, and an increased heart rate.
The Opium Withdrawal Syndrome drugs in development market research report provide comprehensive information on the therapeutics under development for Opium Withdrawal Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Opium Withdrawal Syndrome and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Opium Withdrawal Syndrome | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 15 molecules, with 14 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Opium Withdrawal Syndrome therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Opium Withdrawal Syndrome pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Opium Withdrawal Syndrome treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Aether Therapeutics IncAnanda Scientific Inc
AphioTx Inc
BDH Pharma LLC
BioXcel Therapeutics Inc
Chiesi Farmaceutici SpA
Chiromics LLC
MediciNova Inc
Mount Sinai Health System
Pharmnovo AB
Proniras Corp
Sen-Jam Pharmaceutical LLC
Shenzhen ScienCare Pharmaceutical Co Ltd
Trevena Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Opium Withdrawal Syndrome reports